The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gene Therapies for Tumor Treatment Market Research Report 2025
Synopsis
Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.
The global Gene Therapies for Tumor Treatment market was valued at US$ 4915 million in 2023 and is anticipated to reach US$ 20270 million by 2030, witnessing a CAGR of 20.1% during the forecast period 2024-2030.
The gene therapies for tumor treatment market is driven by the growing need for targeted and personalized cancer therapies and the increasing focus on innovative treatment approaches. Gene therapies involve the introduction of therapeutic genes into cancer cells to target and destroy tumors or inhibit their growth. The rise in the incidence of cancer and the limitations of conventional cancer treatments contribute to market growth. Moreover, advancements in gene editing technology and the understanding of tumor genetics have improved the development of effective gene therapies. However, the market also faces challenges, including the complexity of tumor heterogeneity and the potential for off-target effects in gene editing. Additionally, addressing regulatory and ethical considerations and ensuring accessibility and affordability can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer safe and efficient gene therapies, collaborate with oncology centers to conduct clinical trials and address specific tumor types, and address the challenges to meet the increasing demand for effective and transformative cancer treatments.
This report aims to provide a comprehensive presentation of the global market for Gene Therapies for Tumor Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapies for Tumor Treatment.
Report Scope
The Gene Therapies for Tumor Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapies for Tumor Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapies for Tumor Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Gilead Sciences
Amgen
Shanghai Sunway
Sibiono
Segment by Type
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapies for Tumor Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.
The global Gene Therapies for Tumor Treatment market was valued at US$ 4915 million in 2023 and is anticipated to reach US$ 20270 million by 2030, witnessing a CAGR of 20.1% during the forecast period 2024-2030.
The gene therapies for tumor treatment market is driven by the growing need for targeted and personalized cancer therapies and the increasing focus on innovative treatment approaches. Gene therapies involve the introduction of therapeutic genes into cancer cells to target and destroy tumors or inhibit their growth. The rise in the incidence of cancer and the limitations of conventional cancer treatments contribute to market growth. Moreover, advancements in gene editing technology and the understanding of tumor genetics have improved the development of effective gene therapies. However, the market also faces challenges, including the complexity of tumor heterogeneity and the potential for off-target effects in gene editing. Additionally, addressing regulatory and ethical considerations and ensuring accessibility and affordability can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer safe and efficient gene therapies, collaborate with oncology centers to conduct clinical trials and address specific tumor types, and address the challenges to meet the increasing demand for effective and transformative cancer treatments.
This report aims to provide a comprehensive presentation of the global market for Gene Therapies for Tumor Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapies for Tumor Treatment.
Report Scope
The Gene Therapies for Tumor Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapies for Tumor Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapies for Tumor Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Gilead Sciences
Amgen
Shanghai Sunway
Sibiono
Segment by Type
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapies for Tumor Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Gene Induced Immunotherapy
1.2.3 Oncolytic Virotherapy
1.2.4 Gene Transfer
1.3 Market by Application
1.3.1 Global Gene Therapies for Tumor Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapies for Tumor Treatment Market Perspective (2019-2030)
2.2 Gene Therapies for Tumor Treatment Growth Trends by Region
2.2.1 Global Gene Therapies for Tumor Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Therapies for Tumor Treatment Historic Market Size by Region (2019-2024)
2.2.3 Gene Therapies for Tumor Treatment Forecasted Market Size by Region (2025-2030)
2.3 Gene Therapies for Tumor Treatment Market Dynamics
2.3.1 Gene Therapies for Tumor Treatment Industry Trends
2.3.2 Gene Therapies for Tumor Treatment Market Drivers
2.3.3 Gene Therapies for Tumor Treatment Market Challenges
2.3.4 Gene Therapies for Tumor Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapies for Tumor Treatment Players by Revenue
3.1.1 Global Top Gene Therapies for Tumor Treatment Players by Revenue (2019-2024)
3.1.2 Global Gene Therapies for Tumor Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapies for Tumor Treatment Revenue
3.4 Global Gene Therapies for Tumor Treatment Market Concentration Ratio
3.4.1 Global Gene Therapies for Tumor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapies for Tumor Treatment Revenue in 2023
3.5 Gene Therapies for Tumor Treatment Key Players Head office and Area Served
3.6 Key Players Gene Therapies for Tumor Treatment Product Solution and Service
3.7 Date of Enter into Gene Therapies for Tumor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapies for Tumor Treatment Breakdown Data by Type
4.1 Global Gene Therapies for Tumor Treatment Historic Market Size by Type (2019-2024)
4.2 Global Gene Therapies for Tumor Treatment Forecasted Market Size by Type (2025-2030)
5 Gene Therapies for Tumor Treatment Breakdown Data by Application
5.1 Global Gene Therapies for Tumor Treatment Historic Market Size by Application (2019-2024)
5.2 Global Gene Therapies for Tumor Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Therapies for Tumor Treatment Market Size (2019-2030)
6.2 North America Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Therapies for Tumor Treatment Market Size by Country (2019-2024)
6.4 North America Gene Therapies for Tumor Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapies for Tumor Treatment Market Size (2019-2030)
7.2 Europe Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Therapies for Tumor Treatment Market Size by Country (2019-2024)
7.4 Europe Gene Therapies for Tumor Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapies for Tumor Treatment Market Size (2019-2030)
8.2 Asia-Pacific Gene Therapies for Tumor Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapies for Tumor Treatment Market Size (2019-2030)
9.2 Latin America Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Therapies for Tumor Treatment Market Size by Country (2019-2024)
9.4 Latin America Gene Therapies for Tumor Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapies for Tumor Treatment Market Size (2019-2030)
10.2 Middle East & Africa Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Gene Therapies for Tumor Treatment Introduction
11.1.4 Novartis Revenue in Gene Therapies for Tumor Treatment Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Gene Therapies for Tumor Treatment Introduction
11.2.4 Gilead Sciences Revenue in Gene Therapies for Tumor Treatment Business (2019-2024)
11.2.5 Gilead Sciences Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Gene Therapies for Tumor Treatment Introduction
11.3.4 Amgen Revenue in Gene Therapies for Tumor Treatment Business (2019-2024)
11.3.5 Amgen Recent Development
11.4 Shanghai Sunway
11.4.1 Shanghai Sunway Company Detail
11.4.2 Shanghai Sunway Business Overview
11.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Introduction
11.4.4 Shanghai Sunway Revenue in Gene Therapies for Tumor Treatment Business (2019-2024)
11.4.5 Shanghai Sunway Recent Development
11.5 Sibiono
11.5.1 Sibiono Company Detail
11.5.2 Sibiono Business Overview
11.5.3 Sibiono Gene Therapies for Tumor Treatment Introduction
11.5.4 Sibiono Revenue in Gene Therapies for Tumor Treatment Business (2019-2024)
11.5.5 Sibiono Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
